TIFFANY WILLIAMS: Open Payments
NPI 1972955763 · BLUFFTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 17 payments from 10 companies in 2025. Trend: 2023 $533 · 2024 $856 · 2025 $378
Food & beverage: $357Education: $20
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 3 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Travere Therapeutics, Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Novo Nordisk Inc | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Mannkind Corporation | 1 | $24 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
Products named: IBSRELA, Kerendia, Fabhalta, FARXIGA, JYNARQUE, PURIFIED CORTROPHIN GEL, AFREZZA, RAYALDEE.
Industry payments across SC — which companies pay providers there.
